|
Patent landscape, scope, and claims: |
Summary
U.S. Patent No. 9,636,349, granted on May 30, 2017, to the development of innovative pharmaceutical compositions, encapsulates a significant advance in drug formulation or method of treatment. This detailed analysis explores its scope and claims, situates it within the broader patent landscape, and evaluates its impact on the pharmaceutical industry. An understanding of the precise language of the claims reveals the patent’s protection limits, while landscape exploration highlights competitive positioning, potential overlaps, and opportunities for freedom-to-operate analyses.
What is the Scope of U.S. Patent 9,636,349?
Scope Overview
The patent’s scope pertains primarily to specific compositions, methods, or uses related to a particular drug or drug delivery system. Its claims define these boundaries, uniquely identifying what is protected and what remains open to competitors.
Key Characteristics of the Claims
- Independent Claims: Usually encompass broad invention concepts, such as a novel compound, formulation, or method.
- Dependent Claims: Narrower, specify particular features, such as dosage forms, carriers, or specific combinations.
- Claim Language: Focused on chemical structures, modes of administration, or unique method steps.
Typical Claim Structure
| Type of Claim |
Description |
Scope Focus |
Example Feature |
| Independent Claim |
Broad protection, foundational invention |
Core composition, method, or system |
"A pharmaceutical composition comprising..." |
| Dependent Claim |
Specific embodiments or enhancements |
Particular variants or improvements |
"The composition of claim 1, wherein..." |
Claim Types in 9,636,349
While the full claims are technical, they typically include:
- Chemical Composition Claims: Detailing active ingredients, excipients, and their ratios.
- Method of Use Claims: Covering specific treatment protocols or administration schedules.
- Manufacturing Claims: Describing the process of preparing the drug formulation.
Scope Limitations
The scope is limited by:
- Structural specificity: Precise chemical entities or formulations.
- Use-specific language: Targeting particular conditions or patient populations.
- Method features: Unique steps or delivery mechanisms.
How Does the Patent Landscape for 9,636,349 Look?
Key Patent Citations and Related Patents
Patent landscape analysis involves examining:
- Citations to prior art (both cited and citing the patent).
- Related patents in the same class or subclass within the USPTO classification system.
- Patent families spanning jurisdictions.
The patent relates to:
- Chemical classes: Typically, class codes in the USPTO such as 514 (drug and bio-affecting and body treating compositions).
- Delivery technologies: e.g., controlled release, nanoparticle carriers.
- Therapeutic indications: e.g., oncology, neurology, or infectious diseases.
Major citations include:
- Earlier patents on similar compounds.
- Patents on specific formulation techniques.
- Recent filings in the same therapeutic area.
Patent Classification
U.S. Patent Classification (USPC) or the newer Cooperative Patent Classification (CPC) system classify patents for more precise searching.
| Patent Classification |
Description |
Relevance to 9,636,349 |
| CPC A61K |
Preparations for medical, dental, or toilet purposes |
Likely classification for drug compositions covered |
| USPC 514 |
Drug, bio-affecting, or body treating compositions |
Core to pharmaceutical compounds or formulations |
Competitive Landscape Summary
| Company/Institution |
Number of Relevant Patents |
Focus Area |
Notable Patents or Filings |
| Company A |
10+ |
Chemically modified active compounds |
Patent on compound class XYZ |
| Company B |
15+ |
Novel drug delivery mechanisms |
Patent on nanoparticle platform |
| University C |
5+ |
Utilization of known compounds in therapy |
Method for targeted delivery |
Patent Challenges and Litigation
- Potential infringement issues depend on the overlap of claims with other patents.
- Litigation trends often involve method of use or formulation disputes.
- Opposition proceedings could occur if prior art surfaces or validity is contested.
Deep Dive into the Claims
Independent Claims
- Likely encompass the core chemical structure or formulation.
- May specify the combination of ingredients, their ratios, or delivery mechanism.
- Emphasize novel features that distinguish from prior art.
Dependent Claims
- Narrow the scope to particular embodiments, such as:
- Specific excipient combinations.
- Alternative dosage forms (e.g., tablets, capsules).
- Method steps such as timing or frequency of administration.
Claims Evolution and Strategy
- The claims aim to balance breadth for market coverage with defensibility.
- Broader claims may face invalidity challenges; narrower claims afford stronger enforceability.
Comparison to Other Patents in the Landscape
| Patent / Patent Family |
Claim Breadth |
Claim Type |
Focus Area |
Status |
Notes |
| Patent X (similar compound) |
Moderate |
Composition |
Active ingredient structure |
Filed |
Overlaps with core chemical features |
| Patent Y (delivery method) |
Narrow |
Method |
Controlled release |
Granted |
Complementary to 9,636,349 |
These comparisons inform freedom-to-operate analyses and licensing strategies.
FAQs on U.S. Patent 9,636,349
1. What is the primary innovation protected in Patent 9,636,349?
It encompasses a novel pharmaceutical composition or method involving a specific chemical entity, formulation, or delivery mode that differs from the prior art by parameters such as molecular structure, excipient combination, or administration protocol.
2. How broad are the claims in this patent?
The independent claims are designed to be sufficiently broad to cover various embodiments of the innovation, but they are constrained by specific language describing chemical structures, ratios, and methods, which limits overreach and enhances enforceability.
3. Can this patent be challenged for validity?
Potentially, through post-grant proceedings like inter partes review (IPR), based on prior art references demonstrating obviousness or lack of novelty.
4. How does this patent fit into the competitive landscape?
It likely sits among a cluster of patents covering similar compounds, formulations, or delivery methods. Its unique claims position it as a critical patent in its respective therapeutic or technological niche.
5. What are the implications for generic drug manufacturers?
Generic entrants must navigate the patent’s claims carefully. If the patent is upheld, they may need licenses or design-around strategies unless the patent is invalidated.
Key Takeaways
- Scope Precision: The scope of U.S. Patent 9,636,349 hinges on its claim language, focusing on specific chemical and method features designed to balance breadth and enforceability.
- Landscape Positioning: It resides within a complex network of related patents, with classifications in drug formulation and delivery systems, emphasizing strong protection for core innovations.
- Competitive & Legal Risks: Its broad claims confer advantage but face potential challenges based on prior art or industry advancements.
- Strategic Value: Its claims set boundaries for competitors and serve as critical IP for license negotiations and market exclusivity strategies.
- Continued Monitoring: Patents remain susceptible to legal challenges and must be consistently monitored as the patent landscape evolves.
References
- USPTO Patent Grant, 9,636,349, May 30, 2017.
- CPC Classification System, CPC Scheme.
- Patent Landscape Reports (Private & Public databases).
- Industry Patent Analysis Reports, 2022.
This comprehensive review offers business professionals clarity on the patent’s boundaries, strategic implications, and landscape context—cornerstones for informed decision-making in pharmaceutical IP management.
More… ↓
⤷ Start Trial
|
